Construction of diverse adeno-associated viral libraries for directed evolution of enhanced gene delivery vehicles

Nature Protocols

Volumn 1, Issue 2, 2006, Pages 701-706

  Koerber, James T ^a   Maheshri, Narendra ^b   Kaspar, Brian K ^c   Schaffer, David V ^a  

^a University of California   (United States)

^b Massachusetts Institute of Technology Cambridge   (United States)

^c OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENO ASSOCIATED VIRUS; ARTICLE; CELL LINE; DIRECTED MOLECULAR EVOLUTION; GENE LIBRARY; GENE TARGETING; GENE THERAPY; GENE VECTOR; GENETIC TRANSFECTION; GENETICS; HUMAN; METHODOLOGY; MUTAGENESIS; PLASMID; VIRUS GENOME;

CELL LINE; DEPENDOVIRUS; DIRECTED MOLECULAR EVOLUTION; GENE LIBRARY; GENE TARGETING; GENE THERAPY; GENETIC VECTORS; GENOME, VIRAL; HUMANS; MUTAGENESIS; PLASMIDS; TRANSFECTION;

EID: 34548743469     PISSN: 17542189     EISSN: 17502799     Source Type: Journal    
DOI: 10.1038/nprot.2006.93     Document Type: Article

References (30)

1. Mulligan, R.C. The basic science of gene therapy. Science 260 926-932(1993).
2. Verma, I.M. & Weitzman, M.D. Gene therapy: Twenty-first century medicine. Annu. Rev. Biochem. 74, 711-738 (2005).
3. Kay, M.A. et al. Evidence for gene transfer and expression of factor IX in hemophilia B patients treated with an AAV vector. Nat. Genet. 24, 257-261 (2000).
4. Manna, C.S. et al. AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B. Blood 101 2963-2972 (2003).
5. Srivastava, A., Lusby, E.W. & Berns, K.I. Nucleotide sequence and organization of the adeno-associated virus 2 genome. J. Virol. 45, 555-564 (1983).
6. Samulski, R.J., Chang, L.S. & Shenk, T. Helper-free stocks of recombinant adeno-associated viruses: Normal integration does not require viral gene expression. J. Virol. 63, 3822-3828 (1989).
7. Chiorini, J.A., Kim, F., Yang, L. & Kotin, R.M. Cloning and characterization of adeno-associated virus type 5. J. Virol. 73 1309-1319 (1999).
8. Gao, G. et al. Clades of Adeno-associated viruses are widely disseminated in human tissues. J. Virol. 78, 6381-6388 (2004).
9. Gao, G.P. et al. Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy. Proc. Natl. Acad. Sci. USA 99, 11854-11859 (2002).
10. Xie, Q. et al. The atomic structure of adeno-associated virus (AAV-2), a vector for human gene therapy. Proc. Natl. Acad. Sci. USA 99, 10406-10410 (2002).
11. Rabinowitz, J.E., Xiao, W. & Samulski, R.J. Insertional mutagenesis of AAV2 capsid and the production of recombinant virus. Virology 265, 274-285 (1999).
12. Wu, P. et al. Mutational analysis of the adeno-associated virus type 2 (AAV2) capsid gene and construction of AAV2 vectors with altered tropism. J. Virol. 74, 8635-8647 (2000).
13. Lochrie, M.A. et al. Mutations on the external surfaces of adeno-associated virus type 2 capsids that affect transduction and neutralization. J. Virol. 80, 821-834 (2006).
14. Bartlett, J.S., Kleinschmidt, J., Boucher, R.C. & Samulski, R.J. Targeted adeno-associated virus vector transduction of nonpermissive cells mediated by a bispecific F(ab'gamma)2 antibody. Nat. Biotechnol. 17, 181-186 (1999).
15. Girod, A. et al. Genetic capsid modifications allow efficient re-targeting of adeno-associated virus type 2. Nat. Med. 5, 1052-1056 (1999).
16. Muller, O.J. et al. Random peptide libraries displayed on adeno-associated virus to select for targeted gene therapy vectors. Nat. Biotechnol. 21, 1040-1046 (2003).
17. Perabo, L. et al. In vitro selection of viral vectors with modified tropism: The adeno-associated virus display. Mol. Ther. 8, 151-157 (2003).
18. Opie, S.R., Warrington, K.H., Jr., Agbandje-McKenna, M., Zolotukhin, S. & Muzyczka, N. Identification of amino acid residues in the capsid proteins of adeno-associated virus type 2 that contribute to heparan sulfate proteoglycan binding. J. Virol. 77, 6995-7006 (2003).
19. Moskalenko, M. et al. Epitope mapping of human anti-adeno-associated virus type 2 neutralizing antibodies: Implications for gene therapy and virus structure. J. Virol. 74, 1761-1766 (2000).
20. Wobus, C.E. et al. Monoclonal antibodies against the adeno-associated virus type 2 (AAV-2) capsid: Epitope mapping and identification of capsid domains involved in AAV-2-cell interaction and neutralization of AAV-2 infection. J. Virol. 74, 9281-9293 (2000).
21. Maheshri, N., Koerber, J.T., Kaspar, B.K. & Schaffer, D.V. Directed evolution of adeno-associated virus yields enhanced gene delivery vectors. Nat. Biotechnol. 24, 198-204 (2006).
22. Zhao, H., Giver, L., Shao, Z., Affholter, J.A. & Arnold, F.H. Molecular evolution by staggered extension process (StEP) in vitro recombination. Nat. Biotechnol. 16, 258-261 (1998).
23. Stemmer, W.P. Rapid evolution of a protein in vitro by DNA shuffling. Nature 370, 389-391 (1994).
24. Boder, E.T. & Wittrup, K.D. Yeast surface display for screening combinatorial polypeptide libraries. Nat. Biotechnol. 15, 553-557 (1997).
25. Daugherty, P.S., Chen, G., Iverson, B.L. & Georgiou, G. Quantitative analysis of the effect of the mutation frequency on the affinity maturation of single chain Fv antibodies. Proc. Natl. Acad. Sci. USA 97, 2029-2034 (2000).
26. Soong, N.W. et al. Molecular breeding of viruses. Nat. Genet. 25, 436-439 (2000).
27. Lai, K., Kaspar, B.K., Gage, F.H. & Schaffer, D.V. Sonic hedgehog regulates adult neural progenitor proliferation in viro and in vivo. Nat. Neurosci. 6, 21-27 (2003).
28. Batard, P., Jordan, M. & Wurm, F. Transfer of high copy number plasmid into mammalian cells by calcium phosphate transfection. Gene 270, 61-68 (2001).
29. Rabinowitz, J.E. et al. Cross-dressing the virion: The transcapsidation of adeno-associated virus serotypes functionally defines subgroups. J. Virol. 78, 4421-4432 (2004).
30. Gigout, L. et al. Altering AAV tropism with mosaic viral capsids. Mol. Ther. 11, 856-865 (2005).